Literature DB >> 12379745

RB activation defect in tumor cell lines.

Cristina Broceño1, Scott Wilkie, Sibylle Mittnacht.   

Abstract

Activation of the retinoblastoma (RB) protein through dephosphorylation arises in cells upon exit from M phase and in response to environmental stresses, including DNA damage. We provide here for the first time evidence that these responses are co-ordinately affected in a subset of tumor derived cell lines. We find that RB dephosphorylation is not apparent in these cells during progression into G(1). Importantly these cells also do not respond with RB activation after DNA damage during S phase. Moreover and as a consequence they display phenotypes classically associated with RB(-) cells, showing accelerated apoptosis after DNA damage and DNA re-replication after spindle-checkpoint activation. A large body of literature provides evidence that controls governing inactivation of RB are lost in tumors. The results presented here indicate that the reverse reaction, namely the activation of RB from an inactive precursor, may also be compromised. Our findings indicate that this type of defect may be coupled with hypersensitivity to DNA damage and an increase in genomic instability in response to spindle-checkpoint activation thus bearing potentially important medical implications.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12379745      PMCID: PMC137861          DOI: 10.1073/pnas.212519499

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  23 in total

Review 1.  Perturbation of cell cycle regulators in human cancer.

Authors:  I Palmero; G Peters
Journal:  Cancer Surv       Date:  1996

2.  p53 and pRb prevent rereplication in response to microtubule inhibitors by mediating a reversible G1 arrest.

Authors:  S H Khan; G M Wahl
Journal:  Cancer Res       Date:  1998-02-01       Impact factor: 12.701

3.  High molecular weight protein phosphatase type 1 dephosphorylates the retinoblastoma protein.

Authors:  D A Nelson; N A Krucher; J W Ludlow
Journal:  J Biol Chem       Date:  1997-02-14       Impact factor: 5.157

4.  Monoclonal antibodies specific for underphosphorylated retinoblastoma protein identify a cell cycle regulated phosphorylation site targeted by CDKs.

Authors:  T Zarkowska; S U; E Harlow; S Mittnacht
Journal:  Oncogene       Date:  1997-01-16       Impact factor: 9.867

Review 5.  Control and activity of type-1 serine/threonine protein phosphatase during the cell cycle.

Authors:  J W Ludlow; D A Nelson
Journal:  Semin Cancer Biol       Date:  1995-08       Impact factor: 15.707

6.  Specific enzymatic dephosphorylation of the retinoblastoma protein.

Authors:  J W Ludlow; C L Glendening; D M Livingston; J A DeCarprio
Journal:  Mol Cell Biol       Date:  1993-01       Impact factor: 4.272

Review 7.  Negative regulators of cyclin-dependent kinases and their roles in cancers.

Authors:  M H Lee; H Y Yang
Journal:  Cell Mol Life Sci       Date:  2001-11       Impact factor: 9.261

8.  The fission yeast dis2+ gene required for chromosome disjoining encodes one of two putative type 1 protein phosphatases.

Authors:  H Ohkura; N Kinoshita; S Miyatani; T Toda; M Yanagida
Journal:  Cell       Date:  1989-06-16       Impact factor: 41.582

9.  A cDNA encoding rabbit muscle protein phosphatase 1 alpha complements the Aspergillus cell cycle mutation, bimG11.

Authors:  J H Doonan; C MacKintosh; S Osmani; P Cohen; G Bai; E Y Lee; N R Morris
Journal:  J Biol Chem       Date:  1991-10-05       Impact factor: 5.157

10.  The retinoblastoma protein-associated cell cycle arrest in S-phase under moderate hypoxia is disrupted in cells expressing HPV18 E7 oncoprotein.

Authors:  O Amellem; J A Sandvik; T Stokke; E O Pettersen
Journal:  Br J Cancer       Date:  1998-03       Impact factor: 7.640

View more
  20 in total

1.  Nuclear Envelope Rupture Is Enhanced by Loss of p53 or Rb.

Authors:  Zhe Yang; John Maciejowski; Titia de Lange
Journal:  Mol Cancer Res       Date:  2017-08-15       Impact factor: 5.852

2.  The retinoblastoma tumor suppressor modifies the therapeutic response of breast cancer.

Authors:  Emily E Bosco; Ying Wang; Huan Xu; Jack T Zilfou; Karen E Knudsen; Bruce J Aronow; Scott W Lowe; Erik S Knudsen
Journal:  J Clin Invest       Date:  2006-12-07       Impact factor: 14.808

3.  Commitment point during G0-->G1 that controls entry into the cell cycle.

Authors:  Nicholas C Lea; Stephen J Orr; Kai Stoeber; Gareth H Williams; Eric W-F Lam; Mohammad A A Ibrahim; Ghulam J Mufti; N Shaun B Thomas
Journal:  Mol Cell Biol       Date:  2003-04       Impact factor: 4.272

Review 4.  Tailoring to RB: tumour suppressor status and therapeutic response.

Authors:  Erik S Knudsen; Karen E Knudsen
Journal:  Nat Rev Cancer       Date:  2008-09       Impact factor: 60.716

5.  An overlapping kinase and phosphatase docking site regulates activity of the retinoblastoma protein.

Authors:  Alexander Hirschi; Matthew Cecchini; Rachel C Steinhardt; Michael R Schamber; Frederick A Dick; Seth M Rubin
Journal:  Nat Struct Mol Biol       Date:  2010-08-08       Impact factor: 15.369

6.  Isolation of a novel member of small G protein superfamily and its expression in colon cancer.

Authors:  Wei Yan; Wen-Liang Wang; Feng Zhu; Sheng-Quan Chen; Qing-Long Li; Li Wang
Journal:  World J Gastroenterol       Date:  2003-08       Impact factor: 5.742

7.  Human papillomavirus E7 oncoprotein targets RNF168 to hijack the host DNA damage response.

Authors:  Justine Sitz; Sophie Anne Blanchet; Steven F Gameiro; Elise Biquand; Tia M Morgan; Maxime Galloy; Julien Dessapt; Elise G Lavoie; Andréanne Blondeau; Brandon C Smith; Joe S Mymryk; Cary A Moody; Amélie Fradet-Turcotte
Journal:  Proc Natl Acad Sci U S A       Date:  2019-09-09       Impact factor: 11.205

8.  The hSSB1 orthologue Obfc2b is essential for skeletogenesis but dispensable for the DNA damage response in vivo.

Authors:  Niklas Feldhahn; Elisabetta Ferretti; Davide F Robbiani; Elsa Callen; Stephanie Deroubaix; Licia Selleri; Andre Nussenzweig; Michel C Nussenzweig
Journal:  EMBO J       Date:  2012-08-31       Impact factor: 11.598

9.  Introduction of G1 phase arrest in Human Hepatocellular carcinoma cells (HHCC) by APMCF1 gene transfection through the down-regulation of TIMP3 and up-regulation of the CDK inhibitors p21.

Authors:  Qinlong Li; Wei Yan; Shengquan Cheng; Shuangping Guo; Wenyong Wang; Zhipei Zhang; Li Wang; Jing Zhang; Wenliang Wang
Journal:  Mol Biol Rep       Date:  2006-11-02       Impact factor: 2.742

10.  Resistance of Hypoxic Cells to Ionizing Radiation Is Mediated in Part via Hypoxia-Induced Quiescence.

Authors:  Apostolos Menegakis; Rob Klompmaker; Claire Vennin; Aina Arbusà; Maartje Damen; Bram van den Broek; Daniel Zips; Jacco van Rheenen; Lenno Krenning; René H Medema
Journal:  Cells       Date:  2021-03-10       Impact factor: 6.600

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.